| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |